May 2018—Rosetta Genomics’ stockholders have approved the acquisition of the company by Genoptix, which will immediately begin marketing, selling, and distributing Rosetta Genomics’ products. Genoptix purchased Rosetta Genomics’ precision diagnostics business in March.
Genoptix, 760-268-6200